Archives

  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-07
  • Cell Counting Kit-8 (CCK-8): Sensitive Cell Viability and...

    2025-12-03

    Cell Counting Kit-8 (CCK-8): Sensitive Cell Viability and Proliferation Detection Using WST-8 Chemistry

    Executive Summary: The Cell Counting Kit-8 (CCK-8) is a sensitive water-soluble tetrazolium salt-based cell viability assay utilizing WST-8, which is enzymatically reduced by mitochondrial dehydrogenases in metabolically active cells to yield a quantifiable dye (Huimin Ding et al., 2016, DOI). The assay demonstrates higher sensitivity and lower cytotoxicity than traditional MTT or XTT methods. Quantification is rapid, compatible with high-throughput microplate readers, and does not require solubilization steps. CCK-8 is widely adopted for assessing proliferation, viability, and cytotoxicity in cancer, neurodegenerative, and stem cell studies. The kit is manufactured and distributed by APExBIO, ensuring validated batch-to-batch consistency.

    Biological Rationale

    Reliable cell viability measurement is central to experimental cell biology, pharmacology, and translational research. Cellular metabolic activity, particularly mitochondrial dehydrogenase function, is directly proportional to the number of viable cells within a sample. Assays that exploit this relationship provide a robust readout for cell proliferation and cytotoxicity. The CCK-8 assay leverages WST-8, a water-soluble tetrazolium salt, which is reduced in live cells to produce a colored formazan dye. The intensity of this dye, measured spectrophotometrically, reflects the number of metabolically active cells under defined conditions. Accurate viability assessment is critical in cancer research, drug screening, osteoblast differentiation, and studies of neurodegenerative disease mechanisms (Huimin Ding et al., 2016, DOI).

    Mechanism of Action of Cell Counting Kit-8 (CCK-8)

    CCK-8 uses the tetrazolium salt WST-8, which is reduced by intracellular dehydrogenases in viable cells to produce a water-soluble formazan (methane dye). This reaction occurs in the presence of an electron mediator, typically within a standard culture medium (pH 7.2–7.4, 37°C). The amount of formazan dye generated is proportional to the number of living cells and can be quantified by measuring absorbance at 450 nm using a microplate reader (APExBIO, product page). Unlike MTT, the formazan product is fully soluble in aqueous solutions, eliminating the need for DMSO or other solubilization steps. This streamlines the workflow and reduces cytotoxicity, enabling sequential or multiplexed assays on the same cells. The specificity of the WST-8 reaction ensures low background and high signal-to-noise ratios.

    Evidence & Benchmarks

    • CCK-8 demonstrates linear response in cell numbers ranging from 500 to 50,000 cells per well, with detection sensitivity as low as 100 cells under optimized conditions (Huimin Ding et al., 2016).
    • Formazan dye production is directly proportional to mitochondrial dehydrogenase activity, validated across multiple cell types including MC3T3-E1, C3H10T1/2, and BMSCs (Huimin Ding et al., 2016).
    • Compared to MTT, XTT, and WST-1 assays, CCK-8 yields higher sensitivity and requires no additional solubilization step, minimizing cell loss and assay variability (cal-101.net article).
    • CCK-8 has been reproducibly applied in osteoblast differentiation models to quantify proliferation and viability changes in response to genetic and pharmacological perturbation (Huimin Ding et al., 2016).
    • The K1018 kit from APExBIO is validated for use in 96-well, 24-well, and 384-well plate formats, supporting high-throughput screening (APExBIO product page).

    Applications, Limits & Misconceptions

    CCK-8 is widely used in:

    • Cancer research: Quantifying cancer cell proliferation and cytotoxicity following drug treatment (cck-8assay.com article). This article extends prior discussions by providing explicit benchmarks for sensitivity and workflow.
    • Neurodegenerative disease studies: Assessing neuronal viability in response to genetic or environmental stressors.
    • Osteoblast differentiation: Monitoring proliferation during bone formation research (Huimin Ding et al., 2016, DOI).
    • Cellular metabolic activity assessment: General viability and cytotoxicity screening in diverse cell lines.

    CCK-8 is not a direct measure of cell number but an index of dehydrogenase activity; therefore, metabolic state and cell type may influence results. This article updates earlier overviews by detailing precise conditions and highlighting practical boundaries (osu-03012.com article).

    Common Pitfalls or Misconceptions

    • Low metabolic activity does not always indicate cell death: Some treatments inhibit metabolism without causing lysis.
    • High background in the presence of reducing agents: Antioxidants or reductants in media can artificially elevate readings.
    • Not suitable for non-adherent or extremely low-density cultures: Signal may be below detection threshold for sparse cell populations.
    • Interference by colored compounds: Test agents with intrinsic color near 450 nm can confound absorbance measurements.
    • Results may not be comparable across different cell types without calibration: Baseline dehydrogenase activity varies.

    Workflow Integration & Parameters

    The CCK-8 assay is performed by directly adding the reagent (typically 10 μL per 100 μL culture medium for 96-well plates) to cells, incubating for 1–4 hours at 37°C, and reading absorbance at 450 nm. No washing or solubilization is required. For high-throughput settings, the K1018 kit from APExBIO supports automation and parallel processing. Data normalization to blank controls and use of multiple replicates is recommended. For detailed workflow optimization and troubleshooting, see this guide, which complements this article by offering scenario-based solutions for experimental design and data interpretation.

    Conclusion & Outlook

    Cell Counting Kit-8 (CCK-8) provides a robust, sensitive, and user-friendly solution for cell viability and proliferation assays based on WST-8 reduction. The water-soluble formazan product enables real-time, non-destructive analysis, suitable for high-throughput and multi-parametric workflows. APExBIO's validated kit (K1018) is widely cited in the literature for its reliability. Continued innovations in assay chemistry and workflow integration will expand the utility of CCK-8 in emerging areas of cancer biology, stem cell research, and functional genomics.